Ledger.Open graph →
SEC Form D · filed April 6, 2021

XenoTherapeutics Corp

Offering
$8.0M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Enfield, NH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Jon Adkins · Londonderry, NHExec · DirectorPaul Holzer · Enfield, NHExec · DirectorKrysta Moulton · Arlington, VAExec · DirectorEmily Mainier · Hamburg, NYExec · DirectorMichael Mainier · Hamburg, NYExec · DirectorJames T. Merkel · Columbus, OHExec · DirectorJordan B. Hansell · Columbus, OHExec · DirectorKrysta Moulton · Arlington, VAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗